Difference between revisions of "Danazol (Danocrine)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Autoimmune thrombocytopenic purpura" to "Category:Immune thrombocytopenia") |
m |
||
| Line 7: | Line 7: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
*1971: Initial FDA approval | *1971: Initial FDA approval | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand names:''' Danatrol, Danocrine, Danodiol, Danogen, Drane, Ladogal, Novaprin | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| + | [[Category:Oral medications]] | ||
[[Category:Endocrine therapy]] | [[Category:Endocrine therapy]] | ||
Revision as of 18:48, 23 July 2018
Mechanism of action
Synthetic steroid with multiple mechanisms of action.
Diseases for which it is used
History of changes in FDA indication
- 1971: Initial FDA approval
Also known as
- Brand names: Danatrol, Danocrine, Danodiol, Danogen, Drane, Ladogal, Novaprin